BioAmber Inc.·4

May 16, 5:53 PM ET

Lucquin Denis 4

4 · BioAmber Inc. · Filed May 16, 2013

Insider Transaction Report

Form 4
Period: 2013-05-14
Transactions
  • Purchase

    Common Stock

    2013-05-14+880,0003,802,780 total(indirect: Sofinnova Capital VI FCPR)
  • Purchase

    Common Stock Warrants (right to buy)

    2013-05-14+880,000880,000 total(indirect: Sofinnova Capital VI FCPR)
    From: 2013-08-08Exp: 2017-05-09Common Stock (440,000 underlying)
Footnotes (2)
  • [F1]The reported securities are included within 880,000 Units purchased by Sofinnova Capital VI FCPR on May 14, 2013 for $10.00 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock.
  • [F2]The reporting person is a Managing Director of Sofinnova Capital VI FCPR, the owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    rrd380284.xmlPrimary

    FORM 4